With breakthrough efficacy in gold-standard preclinical models big pharma collaborations now valued over $1 billion, we are seeking an experienced Head of R&D to design the pathway to IND with the goal of moving multiple assets into the Clinic within the next year.
About The Company
High-tech, privately owned Biotech developing a new technology in immunotherapy that has already been shown to be 30 times more effective. The company has demonstrated breakthrough efficacy in gold-standard preclinical models of Multiple Sclerosis (MS) and Type-1 Diabetes (T1D), which serves as proof of concept for the potential utility of their therapy in a wide range of autoimmune diseases.
About The Role
Reporting to the CEO, this position will be responsible for building R&D team and moving multiple assets in Clinical Stages, ideally within the next year.
Will be doing little bit of everything in line with R&D efforts and will be responsible for designing the pathway to IND.
Must Have Requirements
Expertise in peptide-mediated immunotherapy
Expertise in Autoimmune disease
PhD in Immunology or Chemistry related fields
History of successfully leading and developing R&D teams
History of successful leading assets to IND
$250M + Big pharma collaborations valued over $1 billion